XETR
AMI
Market cap3mUSD
Oct 09, Last price
0.14EUR
1D
0.00%
1Q
8.14%
Jan 2017
-94.82%
IPO
-99.09%
Name
Medondo Holding AG
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
medondo holding AG, together with its subsidiaries, provides software solutions in Germany. The company offers practice software comprising Online Diary, an online appointment calendar; Digital anamnesis & clarification, which records patient’s relevant health information before the appointment; Practice marketing & visibility, which publishes regular specialist articles in practice blog, as well as publish specialist articles on channels for an online presence; Form Designer that create customized forms; and Patient Portal, which make documents and forms available digitally and enable patients to make appointments and follow-up appointments. It also provides Self-check-in; Digital patient file, which provides information about patients; Practice TV & patient management which integrate the patient call function directly into the practice TV; Co-treatment portal that shares findings, X-ray images or treatment reports; and Digital documents & signature, provide patients with important documents digitally via the patient portal or by e-mail and have documents signed electronically. In addition, the company offers digital invoices; and Follow-up appointment management & appointment reminders software. Further, it provides product-related services, such as training, consulting, maintenance, and support services. The company was founded in 2003 and is based in Munich, Germany.
Key people
Thomas Kuhmann
Chairman of the Supervisory Board
Juergen Rotter
Member of the Management Board · since 2023
Ulrich Mueller
Deputy Chairman of the Supervisory Board
Andreas Empl
Member of the Supervisory Board · since 2024
Headquarters & legal address
Tattenbachstraße 6, 1. OG
München, BY 80538
DE
München, BY 80538
DE
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||